In our recent Liberty Update, CFIF sounded the alarm on Gigi Sohn, Joe Biden's dangerously extremist…
CFIF on Twitter CFIF on YouTube
Former U.S. Attorney General Agrees: "Hyperpartisan Gigi Sohn Doesn't Belong at the FCC"

In our recent Liberty Update, CFIF sounded the alarm on Gigi Sohn, Joe Biden's dangerously extremist nominee to the Federal Commission (FCC), noting that, "Ms. Sohn is simply too radical to be confirmed to the FCC at a time when Americans rely more than ever on a thriving internet service sector, and the Biden Administration has only itself to blame for its delay in nominating her."

In today's Wall Street Journal, former acting U.S. Attorney General Matthew Whitaker brilliantly echoes the growing consensus that Ms. Sohn is simply too radical in a commentary entitled "Hyperpartisan Gigi Sohn Doesn't Belong on the FCC":

In addition to her hyperpartisan social-media presence, Ms. Sohn has dubbed Fox News 'state-sponsored propaganda' and has urged the FCC to look into whether Sinclair…[more]

December 01, 2021 • 11:55 AM

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
Press Releases
CFIF Opposes State Attorneys General “March-In” Demand on Remdesivir Print E-mail
Thursday, August 06 2020

ALEXANDRIA, VA – This week, a group of state attorneys general issued a joint letter to the United States Department of Health and Human Services (HHS), National Institutes of Health (NIH) and Food and Drug Administration (FDA) demanding that the federal government employ so-called “march-in” rights under the Bayh-Dole Act of 1980 to disregard Gilead Sciences, Inc.’s patent rights on its antiviral drug Remdesivir, or allow their states to do so.  The Center for Individual Freedom (CFIF) strongly opposes their demand.  

“If you seek to bring pharmaceutical innovation to a grinding halt, and deprive Americans of lifesaving drugs, the best way to do it is to flagrantly disregard patent protections for pharmaceutical innovators,” said Timothy Lee, CFIF’s Senior Vice President of Legal and Public Affairs.  “Unfortunately, that’s precisely the path that a misguided group of state attorneys general have decided to pursue.  Violating innovators’ patent rights won’t make drugs cheaper, it will only deprive consumers of potentially beneficial drugs entirely.  America currently produces two-thirds of all new drugs worldwide, and that’s because our nation honors and protects patent rights, it doesn’t violate them,” Lee added.    

“It’s particularly galling that the attorneys’ general seek to leverage the Bayh-Dole Act of 1980 to facilitate their scheme, and as we celebrate the law’s 40th anniversary to boot,” Lee continued.  “The Bayh-Dole Act was passed in order to extend patent rights to universities and nonprofit research entities whose research was assisted by federal funds, not weaken them.”  

Prior to Bayh-Dole, very few innovations partially funded by federal dollars were ever commercially pursued – only 390 in the year prior to its passage.  Forty years later, however, that number approaches 7,500, with over 420,000 inventions and 13,000 new startup enterprises formed.  

In the case of Remdesivir, Gilead Sciences has invested billions of dollars in research, development, testing and now manufacturing of the antiviral drug, including over $1 billion this year alone to expand manufacturing capacity both domestically and abroad.  Moreover, Remdesivir’s patents are held by Gilead Sciences, not other researchers or entities that received federal funding at various points in the drug’s creation and production.  Accordingly, Bayh-Dole doesn’t offer the legal means by which the attorneys general seek to achieve their counterproductive ends.  

Fortunately, HHS officials have expressed strict opposition to this scheme.  “CFIF strongly encourages the Trump Administration, HHS, NIH and FDA to maintain their rejection, and instead strengthen rather than limit patent rights for America’s world-leading pharmaceutical innovators, particularly in this time of critical societal need,” Lee concluded.  

CFIF is a constitutional and free market advocacy organization with over 300,000 supporters and activists nationwide.  

###

 


Page 19 of 230
Quiz Question   
How many gun purchase background checks were processed by the FBI during Thanksgiving Week 2021?
More Questions
Notable Quote   
 
"If you're still wondering why raising the cap on the State and Local Tax (SALT) deduction was important enough to Democrats to sacrifice their stated principles and resort to brazen gimmicks in order to fit it into the reconciliation bill, look no further than the latest release of the IRS's tax migration data, covering tax years 2018-2019.The data shows that certain states continue to alienate their…[more]
 
 
—Andrew Wilford, Policy Analyst at National Taxpayers Union Foundation
— Andrew Wilford, Policy Analyst at National Taxpayers Union Foundation
 
Liberty Poll   

In your Christmas shopping thus far, how are you faring?